Neuroprotective properties of glycosaminoglycans: Potential treatment for neurodegenerative disorders

Neurodegenerative Diseases

Volumn 5, Issue 3-4, 2008, Pages 200-205

  Dudas, B ^a   Rose, M ^b   Cornelli, U ^b   Pavlovich, A ^b   Hanin, I ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Alzheimer's disease; Amyloid; Glycosaminoglycans, neuroprotective properties; Neuroparin; Proteoglycans

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; AMYLOID PROTEIN; CASPASE 3; ETHYLCHOLINE MUSTARD AZIRIDINIUM; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN; NERVE GROWTH FACTOR RECEPTOR; NEUROPARIN; OLIGOSACCHARIDE; PROTEOGLYCAN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLOOD BRAIN BARRIER; COMPETITIVE INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEPOLYMERIZATION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; GAMMA IRRADIATION; HIPPOCAMPUS; IMMUNOREACTIVITY; INHIBITION KINETICS; MOLECULAR WEIGHT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VARICOSIS;

ANIMALS; GLYCOSAMINOGLYCANS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

EID: 40449111690     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000113702     Document Type: Conference Paper

References (33)